One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and ...

Annexon has completed enrollment in its phase 3 ARCHER II trial of vonaprument (formerly ANX007) for dry age-related macular ...

The drug is indicated for the treatment rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

DelveInsight's CD40/CD40L Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Measles is one of 100 viruses that the team at VUMC is systematically making antibodies for by using single-cell sequencing — ...